Pharmaceutical companies at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
14 pharmaceutical companies are at SABCS 2026 — 14 with a booth in the exhibit hall. 14 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–14 of 14 organizations
| Organization | SABCS 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker whose breast cancer medicines include HER2- and TROP2-directed antibody-drug conjugates and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 624 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
BeOne Medicines Basel, Switzerland | |
Global oncology company developing and selling treatments for blood cancers and solid tumors, aiming for wider and more affordable access. | Booth Exhibiting at Booth 1543 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Daiichi Sankyo Tokyo, Japan | |
Japanese drugmaker whose oncology portfolio centers on antibody-drug conjugates, including HER2- and TROP2-directed treatments used in breast cancer. | Booth Exhibiting at Booth 343 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Eli Lilly and Company Indianapolis, IN | |
Global drugmaker whose cancer medicines include treatments for hormone receptor-positive breast cancer. | Booth Exhibiting at Booth 324 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Genentech South San Francisco, CA | |
Roche Group biotechnology company whose breast cancer medicines include HER2-targeted antibodies and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 125 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Gilead Sciences Foster City, CA | |
Biopharma company whose cancer portfolio spans antibody-drug conjugates, small molecules and, through Kite, cell therapies. | Booth Exhibiting at Booth 608 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Jazz Pharmaceuticals Dublin, Ireland | |
Global biopharma company with medicines for serious diseases, including zanidatamab, a HER2-targeted bispecific antibody studied in breast cancer. | Booth Exhibiting at Booth 1642 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Menarini-Stemline New York, NY | |
Oncology company in the Menarini Group that markets elacestrant (Orserdu) for ESR1-mutated, ER+/HER2- advanced breast cancer. | Booth Exhibiting at Booth 309 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Merck & Co. Rahway, NJ | |
Global drugmaker with one of the largest oncology development programs, spanning more than 30 tumor types, including immunotherapy for triple-negative breast cancer. | Booth Exhibiting at Booth 1108 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Novartis Basel, Switzerland | |
Swiss drugmaker whose breast cancer medicines include treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 643, 1142 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Organon Jersey City, NJ | |
Women's health drugmaker whose portfolio includes biosimilars, among them a trastuzumab biosimilar for HER2-positive breast cancer. | Booth Exhibiting at Booth 1209 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Pfizer New York, NY | |
Global drugmaker whose breast cancer medicines include treatments for hormone receptor-positive and HER2-positive disease. | Booth Exhibiting at Booth 1124 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Boehringer Ingelheim Ingelheim am Rhein, Germany | |
Family-owned drugmaker whose oncology pipeline targets cancer cells directly and harnesses the immune system. | Booth Exhibiting at Booth 1551 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Bristol Myers Squibb Princeton, NJ | |
Global biopharma company developing medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience. | Booth Exhibiting at Booth 151 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers from pharmaceutical companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse SABCS 2026 by
Organization type
Focus
- Patient and family support 26
- Genomic and tumor testing 22
- Hormone receptor-positive breast cancer 17
- Clinical trials and research 16
- HER2-positive breast cancer 10
- Liquid biopsy and MRD 10
- AI and data 9
- Screening and early detection 9
- Side effects and supportive care 8
- Breast surgery and biopsy 8
- Metastatic breast cancer 5
- Triple-negative breast cancer 4
- Hereditary risk and genetic testing 4
Exhibit hall
Everyone
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction